Catalyst Wire Dossier Catalyst Wire Dossier

Sanofi Pasteur H5N1 adjuvanted influenza vaccine

Influenza A(H5N1) vaccine, adjuvanted, inactivated, split-virus · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sanofi Pasteur H5N1 adjuvanted influenza vaccine, covering 2014-01-14 to 2014-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults [Phase 1]

See pricing